A PubMed-indexed paper describes thymosin beta-4 as a 43 amino acid, 5 kDa polypeptide that is involved in cell proliferation, migration and differentiation
AOD 9604 differs from full-length growth hormone and GHRH analogues in that it does not activate the growth hormone receptor or stimulate endogenous GH release
it stimulates lipolysis without affecting glucose metabolism, which makes it useful when you need to study fat mobilization independent of insulin pathways, but irrelevant for insulin resistance research
Key Takeaways Physician-led, not a drip bar: every IV session at Perfect B is screened and administered under medical oversight, with personalized formulation rather than a standardized package
Short Answer: BPC-157 remains closer to a research peptide than an approved pharmaceutical, which helps explain the lack of human evidence
Its effectiveness is not in doubt and the process is generally safe in clinics with qualified medical staff, but no procedure involving skin penetration is without risk of infection